NGM BIOPHARMACEUTICALS INC Quarterly Operating Lease, Liability in USD from Q4 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Ngm Biopharmaceuticals Inc quarterly Operating Lease, Liability history and growth rate from Q4 2021 to Q3 2023.
  • Ngm Biopharmaceuticals Inc Operating Lease, Liability for the quarter ending September 30, 2023 was $1.38M.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.38M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.75M Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $4.07M Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $5.39M -$1.3M -19.5% Dec 31, 2022 10-K 2023-02-28
Q4 2021 $6.69M Dec 31, 2021 10-Q 2022-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.